Blau Farmacêutica S.A. (BVMF:BLAU3)
12.93
+0.05 (0.39%)
Aug 29, 2025, 5:07 PM GMT-3
Blau Farmacêutica Revenue
Blau Farmacêutica had revenue of 464.83M BRL in the quarter ending June 30, 2025, a decrease of -0.06%. This brings the company's revenue in the last twelve months to 1.77B, up 12.22% year-over-year. In the year 2024, Blau Farmacêutica had annual revenue of 1.75B with 27.81% growth.
Revenue (ttm)
1.77B
Revenue Growth
+12.22%
P/S Ratio
1.30
Revenue / Employee
930.22K
Employees
1,900
Market Cap
2.30B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.75B | 381.74M | 27.81% |
Dec 31, 2023 | 1.37B | -34.28M | -2.44% |
Dec 31, 2022 | 1.41B | 40.50M | 2.96% |
Dec 31, 2021 | 1.37B | 184.60M | 15.62% |
Dec 31, 2020 | 1.18B | 204.30M | 20.90% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Rede D'Or São Luiz | 52.81B |
Raia Drogasil | 40.96B |
Hypera | 6.66B |
Fleury | 7.84B |
Odontoprev | 2.49B |
Empreendimentos Pague Menos | 13.68B |
Oncoclínicas do Brasil Serviços Médicos | 6.16B |
Diagnósticos da América | 13.93B |